Loading...
OTCM
EPTMF
Market cap34mUSD
Oct 15, Last price  
0.99USD
Name

Epitomee Medical Ltd

Chart & Performance

D1W1MN
OTCM:EPTMF chart
P/E
P/S
40.61
EPS
Div Yield, %
Shrs. gr., 5y
0.41%
Rev. gr., 5y
%
Revenues
735k
000010,000,0000734,685
Net income
-30m
L+457.85%
-3,489,000-3,167,000-11,518,000-15,391,000-5,682,000-5,324,860-29,704,739
CFO
-24m
L-19.78%
-2,788,0006,748,000-5,758,000-9,421,000-7,922,000-30,148,372-24,185,976

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Epitomee Medical Ltd, an Israeli-based biomedical enterprise established in 2005, specializes in creating and distributing oral therapeutic devices globally. Its flagship product, a capsule, is designed to assist with weight management, decrease waist circumference, and reduce factors contributing to cardiovascular risk. The company maintains a strategic alliance with Nestlé Health Science S.A. for the advancement and market introduction of this innovative weight loss solution.
IPO date
Dec 15, 2021
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT